MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Cash and cashequivalents$293,651K Short-term investments,available-for-sale$126,370K Prepaid expenses andother current assets$14,602K Restricted cash$6,337K Accounts receivable$1,861K Total current assets$442,821K Long-term investments,available-for-sale$50,159K Other assets$23,582K Operating leaseright-of-use asset$1,795K Property and equipment,net$293K Total assets$518,650K Total liabilities andstockholders equity$518,650K Total stockholdersequity$422,387K Total liabilities$96,263K Accumulated deficit-$743,689K Accumulated othercomprehensive loss-$107K Additional paid-in capital$1,166,180K Total currentliabilities$95,839K Long-term operating leaseliability$424K Common stock, 0.0001par value...$3K Accrued liabilities$71,349K Accrued indirect taxliabilities$15,073K Accounts payable$4,351K Accrued compensationand benefits$3,506K Current portion ofoperating lease liability$1,560K
Balance Sheet
source: myfinsight.com

Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics, Inc. (CDTX)